![Anne-Marie O'Farrell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anne-Marie O'Farrell
Directeur Technique/Scientifique/R&D chez
SAGIMET BIOSCIENCES INC.
Profil
Anne-Marie O'Farrell is Chief Scientific Officer at Sagimet Biosciences, Inc. since 2013.
Former positions include Director-Discovery Biology at Phenomix Corp.
in 2010, Executive Director-Translational Medicine at Pathway Therapeutics, Inc., Director-Translational Medicine at Pathway Therapeutics Ltd. from 2010 to 2011, Group Leader at Sugen, Inc., Principal at Systemix, Inc. in 2000, and Principal at DNAX Research, Inc. in 1998.
Education includes a doctorate from The University of Manchester conferred in 1993 and an undergraduate degree from University College Cork conferred in 1989.
Postes actifs de Anne-Marie O'Farrell
| Sociétés | Poste | Début |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Directeur Technique/Scientifique/R&D | 01/01/2016 |
Anciens postes connus de Anne-Marie O'Farrell
| Sociétés | Poste | Fin |
|---|---|---|
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Corporate Officer/Principal | 01/07/2010 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Corporate Officer/Principal | 01/01/2000 |
DNAX Research, Inc. | Corporate Officer/Principal | 01/01/1998 |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Corporate Officer/Principal | - |
Pathway Therapeutics, Inc.
 Pathway Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer and inflammatory diseases | Corporate Officer/Principal | - |
Formation de Anne-Marie O'Farrell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Pathway Therapeutics, Inc.
Pathway Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer and inflammatory diseases | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Cork
 University College Cork Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNAX Research, Inc. | |
Pathway Therapeutics Ltd.
 Pathway Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
